Washington, DC - The use of a paclitaxel-eluting stent is associated with wider luminal diameter and less late loss than the use of a bare-metal stent among patients with ST-elevation MI (STEMI) ...

Drug-eluting stents are safe and effective for use in patients who had severe heart attacks, but the potential risk of blood clots needed more study before the devices could be recommended for all ...

ATLANTA -- March 11, 2006 -– Patients treated with the CYPHER® Sirolimus-eluting Coronary Stent continued to experience significantly better long-term clinical outcomes than those who received a bare ...

Using a stent graft to keep open failing arteriovenous dialysis grafts results in better patency and fewer reinterventions than angioplasty alone. Twelve-month results of the RENOVA trial were ...

CYPHER® Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared To Bare Metal Stents In Five-Year Randomized Clinical Trial With No Differences In Long-Term Safety Vienna, ...

Dallas, TX - Drug-coated stents may offer improvements over bare-metal stents in bifurcated vessels, but clinical outcomes are still hampered by high restenosis rates in side branch lesions, as well ...

Data on the use of stents and stent grafts in the treatment of vascular-access-related stenoses are conflicting. In a retrospective review, Vesely et al. evaluated the outcomes of 51 hemodialysis ...

New data from a Spanish study presented at the 2005 American Heart Association Scientific Sessions found that patients with bifurcation lesions fared significantly better when treated with the CYPHER® ...

HERZLIA, Israel--(BUSINESS WIRE)--Endospan, a pioneer in endovascular solutions for the Aortic Arch, today announced the completion of enrollment for the primary arm of its TRIOMPHE Investigational ...

Tryton remains on schedule to file pre-market approval application for its Side Branch Stent in 2015 DURHAM, N.C. Tryton Medical, Inc., the leading developer of stents designed to treat bifurcation ...